Internal Medicine, Rheumatology · Memphis, MO
NPI
1730293705
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
10
Medicare group memberships
Hospitals
5
Hospital affiliations
Sigler Ave
Memphis, MO, 63555
Phone (660) 465-2828
Groups this clinician bills Medicare through
Medicare paid, 2024
$109K
4,517 services
Medicare patients, 2024
216
Average age 73
Drug cost, 2024
$6.7M
5,633 prescriptions
Company payments, 2025
$16K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert W Jackson was code J0897 (injection, denosumab, 1 mg), 3,600 times for 43 patients. In total Robert W Jackson billed 4,517 services in 19 codes, and Medicare paid $109K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 3,600 | 43 | $20.29 | $73K |
| 99213 Office E&M - Established | Office | 227 | 135 | $45.98 | $10K |
| 99214 Office E&M - Established | Office | 83 | 60 | $67.46 | $5,599 |
| 96372 Injection Administration | Office | 70 | 48 | $8.95 | $626 |
| 99212 Office E&M - Established | Office | 46 | 40 | $38.20 | $1,757 |
| 20610 Joint Injection | Office | 23 | 15 | $46.89 | $1,078 |
| 99204 Office E&M - New | Office | 12 | 12 | $106.96 | $1,284 |
By year: 2022 $938K for 99,841 services; 2023 $466K for 43,890 services; 2024 $109K for 4,517 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 117 | 78 | $8.40 | $983 |
| 85025 Blood Count | 82 | 47 | $7.61 | $624 |
| 85651 Clinical Chemistry | 78 | 53 | $4.18 | $326 |
| 80053 Clinical Chemistry | 63 | 43 | $10.35 | $652 |
| 86140 Clinical Chemistry | 52 | 41 | $5.08 | $264 |
| 80076 Clinical Chemistry | 19 | 11 | $8.01 | $152 |
| 80061 Clinical Chemistry | 15 | 12 | $13.12 | $197 |
| 86141 Clinical Chemistry | 13 | 12 | $12.69 | $165 |
Medicare prescription drug claims, 2024
In 2024, the drug Robert W Jackson prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 801 prescriptions and refills. In total Robert W Jackson wrote 5,633 Medicare prescriptions that cost $6.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 801 | 1,287 | 185 | $27K |
| Prednisone Generic | 567 | 798 | 138 | $2,927 |
| Methotrexate Methotrexate Sodium | 397 | 552 | 84 | $6,364 |
| Allopurinol Generic | 362 | 559 | 77 | $2,327 |
| Tramadol Hcl Generic | 345 | 357 | 72 | $4,891 |
| Leflunomide Generic | 340 | 511 | 89 | $13K |
| Duloxetine Hcl Generic | 323 | 452 | 68 | $5,306 |
| Gabapentin Generic | 198 | 238 | 43 | $3,146 |
| Rinvoq Upadacitinib | 112 | 114 | 16 | $723K |
| Pregabalin Generic | 92 | 108 | 21 | $1,776 |
| Sulfasalazine Generic | 88 | 104 | 15 | $1,086 |
| Cyclobenzaprine Hcl Generic | 78 | 92 | 19 | $820 |
| Meloxicam Generic | 75 | 139 | 24 | $315 |
| Metformin Hcl Generic | 74 | 110 | 21 | $454 |
| Ozempic Semaglutide | 68 | 85 | 12 | $73K |
Brand drugs: - claims; generic drugs: 4,790 claims; opioid claims: 493.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert W Jackson $16K ($16K in general payments such as food, travel and fees) from 11 companies. The largest payer was Mallinckrodt Hospital Products Inc. with $14K.
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 16 | $14K |
| Abbvie Inc. ABBV | 44 | $974 |
| Amgen Inc. AMGN | 38 | $686 |
| UCB, Inc. UCB.BR | 11 | $250 |
| Janssen Biotech, Inc. JNJ | 4 | $188 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $170 |
| Lilly USA, LLC LLY | 6 | $141 |
| Radius Health, Inc. | 3 | $78.08 |
| Genzyme Corporation SNY | 1 | $65.03 |
| ANI Pharmaceuticals, Inc. ANIP | 1 | $19.22 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.